
While open retroperitoneal lymph node dissection (RPLND) is the primary method for the dissection of retroperitoneal lymph nodes, robotic RPLND has demonstrated lower blood loss, shorter length of stay (LOS), faster recovery, and superior cosmetic results.
Julian Chavarriaga, MD, and colleagues conducted a retrospective review of patients with testicular cancer who underwent primary open (O-RPLND) or robotic (R-RPLND) RPLND to evaluate oncological risks and benefits.
The study was presented at the 2024 American Urological Association Annual Meeting.